These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6159902)

  • 1. [On the decongesting effect of the novel imidazole derivative N-(2-imidazolin-2-yl)-N-(4-indanyl)amine (indanazoline) (author's transl)].
    Masing H; Bengel HJ
    Arzneimittelforschung; 1980; 30(10):1785-7. PubMed ID: 6159902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacology of N-(2-imidazolin-2-yl)-N-(4-indanyl)amino (indanazoline), a new vasoconstrictive imidazoline compound].
    Kretzschmar R; Lehmann HD; Gries J; Kuhne J; Neumann W
    Arzneimittelforschung; 1980; 30(10):1746-60. PubMed ID: 7192114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Temperature and humidity profile of the paranasal sinuses before and after mucosal decongestion by xylometazolin].
    Keck T; Leiacker R; Schick M; Rettinger G; Kühnemann S
    Laryngorhinootologie; 2000 Dec; 79(12):749-52. PubMed ID: 11199458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Synthesis of N-(2-imidazolin-2-yl)-N-(4-indanyl)amine (indanazoline) (author's transl)].
    May HJ
    Arzneimittelforschung; 1980; 30(10):1733-7. PubMed ID: 7192113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [On the galenical development of a nose spray from N-(2-imidazolin-2-yl)-N-(4-indanyl)amine monohydrochloride (indanazoline) (author's transl)].
    Dechow HJ; Lämmerhirt K; Pich CH; Schikarski M
    Arzneimittelforschung; 1980; 30(10):1738-46. PubMed ID: 6159899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of topical tuaminoheptane combined with N-acetyl-cysteine in reducing nasal resistance. A double-blind rhinomanometric study versus xylometazoline and placebo.
    Cogo A; Chieffo A; Farinatti M; Ciaccia A
    Arzneimittelforschung; 1996 Apr; 46(4):385-8. PubMed ID: 8740084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rhinomanometric tests of the effect of nasivinettes in normal subjects (author's transl)].
    Ey W; Skevas A
    Laryngol Rhinol Otol (Stuttg); 1974 Mar; 53(5):352-7. PubMed ID: 4136431
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacokinetic study on N-(2-imidazolin-2-yl)-N-(4-indanyl)amine (indanazoline), a new rhinologic drug].
    Neumann B; Brode E; Traut M
    Arzneimittelforschung; 1980; 30(10):1771-85. PubMed ID: 6159901
    [No Abstract]   [Full Text] [Related]  

  • 9. Nasal airway resistance after decongestion with a nasal spray or a bellows device.
    Jessen M; Ivarsson A; Malm L
    Rhinology; 1996 Mar; 34(1):28-31. PubMed ID: 8739865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of different preparations of nasal decongestants on ciliary beat frequency in vitro.
    Deitmer T; Scheffler R
    Rhinology; 1993 Dec; 31(4):151-3. PubMed ID: 7511251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adverse effect of long-term use of vasoconstrictive drops on the nasal mucosa].
    Burmeĭster LK; Butule EA
    Vestn Otorinolaringol; 1975; (4):71-3. PubMed ID: 52936
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of pharmacologic decongestion in the generation of rhinomanometric norms for the nasal airway.
    Jessen M; Malm L
    Am J Otolaryngol; 1988; 9(6):336-40. PubMed ID: 2465702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained use of xylometazoline nasal spray shortens the decongestive response and induces rebound swelling.
    Graf P; Juto JE
    Rhinology; 1995 Mar; 33(1):14-7. PubMed ID: 7540314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decongestant activity of a new formulation of xylometazoline nasal spray: a double-blind, randomized versus placebo and reference drugs controlled, dose-effect study.
    Castellano F; Mautone G
    Drugs Exp Clin Res; 2002; 28(1):27-35. PubMed ID: 12073765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immediate effect of benzalkonium chloride in decongestant nasal spray on the human nasal mucosal temperature.
    Lindemann J; Leiacker R; Wiesmiller K; Rettinger G; Keck T
    Clin Otolaryngol Allied Sci; 2004 Aug; 29(4):357-61. PubMed ID: 15270822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On the absorption of decongestive nose-drops-investigation with a radioactive labelled imidazoline-derivate (author's transl)].
    Münzel M; Eichner H
    Laryngol Rhinol Otol (Stuttg); 1975 Nov; 54(11):875-88. PubMed ID: 53769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of protective and therapeutic effects of dexpanthenol on nasal decongestants and preservatives: results of cytotoxic studies in vitro.
    Klöcker N; Rudolph P; Verse T
    Am J Rhinol; 2004; 18(5):315-20. PubMed ID: 15586804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ciliary epithelium and topical decongestants: how to minimize the undesirable events?].
    Laberko EL; Zlobina NV; Radtsig EY; Bogomil'sky MR
    Vestn Otorinolaringol; 2014; (5):76-9. PubMed ID: 25588494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental studies on the effect of various mucosa decongesting nose drops].
    Knothe J; Aschoff E
    Dtsch Gesundheitsw; 1969 Dec; 24(50):2384-8. PubMed ID: 4193269
    [No Abstract]   [Full Text] [Related]  

  • 20. [Toxicity studies on N-(2-imidazolinew-2-yl)-N-(4-indanyl)amine monohydrochloride (indanazoline), a ne rhinologic drug].
    Worstmann W; Leuschner F; Neumann W; Kretzschmar R
    Arzneimittelforschung; 1980; 30(10):1760-71. PubMed ID: 6159900
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.